Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ericson

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Prehospital and Disaster Medicine|May 23, 2001
Proceedings for the 5th Asia-Pacific Conference on Disaster Medicine: creating an agenda for actionM De Grace, D Ericson, H Folz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 6, 2013
PEG length and chemical linkage controls polyacridine peptide DNA polyplex pharmacokinetics, biodistribution, metabolic stability and in vivo gene expressionSanjib Khargharia, Koby Kizzire, Mark D Ericson, et al.
Journal of Medicinal Chemistry|April 22, 2015
Discovery of a β-Hairpin Octapeptide, c[Pro-Arg-Phe-Phe-Dap-Ala-Phe-DPro], Mimetic of Agouti-Related Protein(87-132) [AGRP(87-132)] with Equipotent Mouse Melanocortin-4 Receptor (mMC4R) Antagonist PharmacologyMark D Ericson, Andrzej Wilczynski, Nicholas B Sorensen, et al.
Journal of Oral Rehabilitation|June 19, 2010
Attitudes of some European dental undergraduate students to the placement of direct restorative materials in posterior teethC D Lynch, S E Guillem, B Nagrani, et al.
Tandlakartidningen|May 15, 1983
[Cariology]D Bratthall, D Birkhed, P Carlsson, et al.
ACS Medicinal Chemistry Letters|January 25, 2021
Multiresidue Tetrapeptide Substitutions Yield a 140-fold Selective Melanocortin-3 over Melanocortin-4 Receptor AgonistMark D Ericson, Romessa Shaikh, Courtney M Larson, et al.
Journal of Oral Rehabilitation|September 8, 2010
Attitudes of final-year dental students to bleaching of vital and non-vital teeth in Cardiff, Cork, and MalmöS Hatherell, C D Lynch, F M Burke, et al.
Journal of Clinical Immunology|May 23, 2000
The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapyH M Chapel, G P Spickett, D Ericson, et al.
Journal of Medicinal Chemistry|August 17, 2017
Structure-Activity Relationship Studies on a Macrocyclic Agouti-Related Protein (AGRP) Scaffold Reveal Agouti Signaling Protein (ASP) Residue Substitutions Maintain Melanocortin-4 Receptor Antagonist Potency and Result in Inverse Agonist Pharmacology at the Melanocortin-5 ReceptorMark D Ericson, Katie T Freeman, Sathya M Schnell, et al.
Laboratory Animal Science|October 1, 1980
A new technique for restraint of miceS P Liebenberg, R L Van Almen, F F Schaefers, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Prehospital and Disaster Medicine|May 23, 2001
Proceedings for the 5th Asia-Pacific Conference on Disaster Medicine: creating an agenda for actionM De Grace, D Ericson, H Folz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 6, 2013
PEG length and chemical linkage controls polyacridine peptide DNA polyplex pharmacokinetics, biodistribution, metabolic stability and in vivo gene expressionSanjib Khargharia, Koby Kizzire, Mark D Ericson, et al.
Journal of Medicinal Chemistry|April 22, 2015
Discovery of a β-Hairpin Octapeptide, c[Pro-Arg-Phe-Phe-Dap-Ala-Phe-DPro], Mimetic of Agouti-Related Protein(87-132) [AGRP(87-132)] with Equipotent Mouse Melanocortin-4 Receptor (mMC4R) Antagonist PharmacologyMark D Ericson, Andrzej Wilczynski, Nicholas B Sorensen, et al.
Journal of Oral Rehabilitation|June 19, 2010
Attitudes of some European dental undergraduate students to the placement of direct restorative materials in posterior teethC D Lynch, S E Guillem, B Nagrani, et al.
Tandlakartidningen|May 15, 1983
[Cariology]D Bratthall, D Birkhed, P Carlsson, et al.
ACS Medicinal Chemistry Letters|January 25, 2021
Multiresidue Tetrapeptide Substitutions Yield a 140-fold Selective Melanocortin-3 over Melanocortin-4 Receptor AgonistMark D Ericson, Romessa Shaikh, Courtney M Larson, et al.
Journal of Oral Rehabilitation|September 8, 2010
Attitudes of final-year dental students to bleaching of vital and non-vital teeth in Cardiff, Cork, and MalmöS Hatherell, C D Lynch, F M Burke, et al.
Journal of Clinical Immunology|May 23, 2000
The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapyH M Chapel, G P Spickett, D Ericson, et al.
Journal of Medicinal Chemistry|August 17, 2017
Structure-Activity Relationship Studies on a Macrocyclic Agouti-Related Protein (AGRP) Scaffold Reveal Agouti Signaling Protein (ASP) Residue Substitutions Maintain Melanocortin-4 Receptor Antagonist Potency and Result in Inverse Agonist Pharmacology at the Melanocortin-5 ReceptorMark D Ericson, Katie T Freeman, Sathya M Schnell, et al.
Laboratory Animal Science|October 1, 1980
A new technique for restraint of miceS P Liebenberg, R L Van Almen, F F Schaefers, et al.
Pageof 9